Red Hot Healthcare
  • About
  • Portfolio
  • 🔥Hot Takes
  • Podcast
  • Blog
  • Contact
Select Page

Bayer, with new leadership stepping in, deprioritizes women’s health R&D

by | | Biotech

Bayer, with new leadership stepping in, deprioritizes women’s health R&D mbayer Fri, 03/24/2023 – 13:19

Seen Better days: Digital therapeutics maker lays off 35% of workforce as losses mount

by | | Biotech

Seen Better days: Digital therapeutics maker lays off 35% of workforce as losses mount apark Fri, 03/24/2023 – 12:55

Stuart Peltz, founder of PTC, retires after 25 years as CEO

by | | Biotech

Peltz steered PTC through several setbacks and successes, most notably the development of the spinal muscular atrophy drug Evrysdi. He’ll be replaced by COO Matt Klein.

Karuna’s schizophrenia drug success draws a royalty buyer

by | | Biotech

PureTech Health will sell some of its royalty interest in Karuna’s drug, known as KarXT, after its second successful late-phase trial this week.

Important step towards accurate use of stem cell–based disease models

by | | Biotech

Induced pluripotent stem cells offer great therapeutic potential and are a valuable tool for understanding how different diseases develop. New research shows that such stem cell lines should be regularly screened for genetic mutations to ensure the accuracy of the...
« Older Entries

Recent Posts

  • Episode 78: Rajeev Ronanki
  • BCG’s Tibor Merey gives his “Hot Take” on the emerging Metaverse in healthcare
  • Episode 77: Healthcare’s Taboo Topic
  • Hot Take: Interview with Tom Foley on AI in healthcare, value add in FFS, and lack of equality in access to cures
  • Can generative AI unlock prices in healthcare?

Recent Comments

No comments to show.
  • About
  • Portfolio
  • 🔥Hot Takes
  • Podcast
  • Blog
  • Contact
Copyright © 2023. Red Hot Healthcare.
All Rights Reserved
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}